Market closedNon-fractional

DarioHealth/DRIO

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About DarioHealth

DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.

Ticker

DRIO

Sector

Healthcare

Trading on

NASDAQ

Industry

Health Care Technology

Headquarters

New York, United States

Employees

285

DarioHealth Metrics

BasicAdvanced
$35M
Market cap
-
P/E ratio
-$1.64
EPS
1.53
Beta
-
Dividend rate
$35M
1.53
2.95
2.619
32.757
39.003
-530.24%
-31.39%
-71.67%
1.849
0.44
-11.3
-0.896
-28.58%
-24.71%
26.07%
-22.00%

What the Analysts think about DarioHealth

Analyst Ratings

Majority rating from 3 analysts.
Buy

DarioHealth Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-124.56% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$5.7M
58.33%
Net income
-$7.1M
-50.00%
Profit margin
-124.56%
-68.42%

DarioHealth Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 50.62%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.58
-$0.49
-$0.50
-$0.20
-
Expected
-$0.52
-$0.46
-$0.55
-$0.41
-$0.38
Surprise
11.11%
6.52%
-9.64%
-50.62%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for DarioHealth stock?

DarioHealth (DRIO) has a market cap of $35M as of July 06, 2024.

What is the P/E ratio for DarioHealth stock?

The price to earnings (P/E) ratio for DarioHealth (DRIO) stock is 0 as of July 06, 2024.

Does DarioHealth stock pay dividends?

No, DarioHealth (DRIO) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next DarioHealth dividend payment date?

DarioHealth (DRIO) stock does not pay dividends to its shareholders.

What is the beta indicator for DarioHealth?

DarioHealth (DRIO) has a beta rating of 1.53. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell DarioHealth stock

Buy or sell DarioHealth stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing